Return to homepagePandemic Pact

ReCOVer: A randomised controlled trial testing the efficacy of cognitive behavioural therapy for preventing chronic postinfectious fatigue among patients diagnosed with COVID-19 disease

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    NWO Netherlands

  • Principal Investigator

    Prof. Hans Knoop

  • Research Location

    Netherlands

  • Lead Research Institution

    Amsterdam UMC

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Randomized Controlled Trial

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

A substantial subgroup of the COVID-19 patients is expected to develop chronic fatigue, in other words, severe tiredness persisting longer than six months with the associated detrimental effects on health, functioning and societal participation for the patient. It is assumed that the temporary provision of internet-based cognitive behavioural therapy (iCBT) for fatigue will lead to a significant and clinically relevant reduction in the severity of fatigue after the intervention. The research consists of a randomised, controlled study, with patients with fatigue symptoms three to six months after discharge from hospital or after the diagnosis COVID-19 was established. For this, one group will be treated within iCBT and the other group in a standard manner.